Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy

Acta Psychiatrica Scandinavica

Volumn 96, Issue 5, 1997, Pages 354-361

  De Haan, E ^a,e   Van Oppen, P ^b   Van Balkom, A J L M ^b   Spinhoven, P ^c   Hoogduin, K A L ^d   Van Dyck, R ^b  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^e RIAGG RNW   (Netherlands)

Author keywords

Behaviour therapy; Longitudinal study; Obsessive compulsive disorder; Pharmacotherapy; Prediction

Indexed keywords

FLUVOXAMINE;

ADULT; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMPULSION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030667855     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb09929.x     Document Type: Article

References (35)

1. VAN BALKOM AJLM, VAN OPPEN P, VERMEULEN AW, NAUTA MCE, VORST HCM, VAN DYCK R. A meta-analysis on the treatment of obsessive-compulsive disorder: a comparison of antidepressants, behavior therapy and cognitive therapy. Clin Psychol Rev 1994: 14: 359-381.
2. STEKETEE G, SHAPIRO LJ. Predicting behavioral treatment outcome for agoraphobia and obsessive-compulsive disorder. Clin Psychol Rev 1995: 15: 317-346.
3. COTTRAUX J, MESSY P, MARKS IM, MOLLARD E, BOUVARD M. Predictive factors in the treatment of obsessive-compulsive disorders with fluvoxamine and/of behaviour therapy. Behav Psychother 1993: 21: 45-50.
4. ORLOFF LM, BATTLE MA, BAER L et al. Long-term follow-up of 85 patients with obsessive-compulsive disorder. Am J Psychiatry 1994: 151: 441-442.
5. MARKS IM, HODGSON R, RACHMAN S. Treatment of chronic obsessive-compulsive neurosis by in vivo exposure. A two-year follow-up and issues in treatment. Br J Psychiatry 1975: 127: 349-364.
6. CASTLE DJ, DEALE A, MARKS IM, CUTTS F, CHADHOURY Y, STEWARD A. Obsessive-compulsive disorder: prediction of outcome from behavioural psychotherapy. Acta Psychiatr Scand 1994: 89: 393-398.
7. DEVEAUGH-GEISS J, KATZ R, LANDAU P. Clinical predictors of treatment response in obsessive-compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull 1990: 26: 54-59.
8. ACKERMAN DL, GREENLAND S, BYSTRITSKY A, MORGENSTERN H, KATZ RJ. Predictors of treatment response in obsessive-compulsive disorder: a multivariate analysis from a multicenter trial of clomipramine. J Clin Psychopharmacology 1994: 14: 247-254.
9. KEIJSERS GPJ, HOOGDUIN CAL, SCHAAP CPDR. Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. Br J Psychiatry 1994: 165: 781-786.
10. HOOGDUIN CAL, DUIVENVOORDEN HJ. A decision model in the treatment of obsessive-compulsive neurosis. Br J Psychiatry 1988: 152: 516-521.
11. BAER L, JENIKE MA, BLACK DW, TREECE C, RESENFELD R, GREIST J. Effect of Axis II diagnosis on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992: 49: 862-866.
12. FALS-STEWART W, LUCENTE S. An MCMI cluster typology of obsessive-compulsives: a measure of personality characteristics and its relationship to treatment participation, compliance and outcome in behavior therapy. J Psychiatr Res 1993: 27: 139-154.
13. MAVISSAKALIAN M, HAMANN MS, JONES B. DSM-III personality disorder in obsessive-compulsive disorder: changes with treatment. Compr Psychiatry 1990: 31: 432-437.
14. DREESSEN L, HOEKSTRA R, ARNTZ A. The influence of personality disorders on cognitive behavioral therapy for obsessive-compulsive disorder. Paper presented at the World Congress of Behavioral and Cognitive Therapies, Copenhagen, 1995.
15. STEKETEE G. Personality traits and disorders in obsessive-compulsives. J Anxiety Dis 1990: 4: 351-364.
16. O'SULLIVAN G, MARKS I. Long-term outcome of phobic and obsessive-compulsive disorders after treatment. In: NOYES R et al., ed. Handbook of anxiety disorders. Amsterdam: Elsevier, 1990: 368-373.
17. VAN BALKOM AJM, DE HAAN E, VAN OPPEN P, SPINHOVEN PH, HOOGDUIN CAL, VAN DYCK R. Cognitive-behavioral therapy versus the combination with fluvoxamine in the treatment of obsessive-compulsive disorder. Thesis, Free University, Amsterdam.
18. VAN OPPEN P, DE HAAN E, VAN BALKOM AJLM, SPINHOVEN PH, HOOGDUIN K, VAN DYCK R. Cognitive therapy and exposure in vivo in the treatment of obsessive-compulsive disorder. Behav Res Ther 1995: 33: 379-390.
19. GOODMAN WK, PRICE LH, RASMUSSEN SA et al. The Yale-Brown Obsessive-Compulsive Scale. I. Development, use and reliability. Arch Gen Psychiatry 1989: 46: 1006-1011.
20. GOODMAN WK, PRICE LH, RASMUSSEN SA et al. The Yale-Brown Obsessive-Compulsive Scale. II. Validity. Arch Gen Psychiatry 1989: 46: 1012-1016.
21. BECK AT, WARD CH, MENDELSON M, MOCK JE, ERBAUGH JK. An inventory for measuring depression. Arch Gen Psychiatry 1961: 4: 561-571.
22. DEROGATIS LR. SCL-90: administration scoring and procedures manual-1 for the r(evised) version. Baltimore, MD: Clinical Psychometrics Research Unit, Johns Hopkins University School of Medicine, 1977.
23. HYLER S, REIDER R, SPITZER R. Personality Diagnostic Questionnaire (PDQ). New York: New York State Psychiatric Institute, 1982.
24. KEIJSERS GPJ, HOOGDUIN CAL, SCHAAP CPDR. Motivatie voor psychotherapie: De ontwikkeling van een predictie-instrument (Motivation for psychotherapy, development of a prediction instrument). Gedragstherapie 1991: 24: 195-208.
25. JACOBSON NS, FOLETTE WC, REVENSDORF D. Psychotherapy outcome research: methods for reporting variability and evaluating clinical significance. Behav Therapy 1984: 15: 336-352.
26. id. Behav Res Ther 1993: 31: 693-700.
27. MARKS IM. Fears, phobias, and rituals, panic, anxiety and their disorders. Oxford: Oxford University Press, 1987.
28. WOODY SR, STEKETEE G, CHAMBLESS DL. Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale. Behav Res Ther 1995: 33: 597-605.
29. GOODMAN WK, PRICE LH, DELOADO PL et al. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1990: 47: 577-585.
30. GARFIELD SL. Research on client variables in psychotherapy. In: BERGIN AE, GARFIELD SL, ed. Handbook of psychotherapy and behavior change. New York: Wiley, 1994: 213-257.
31. KEIJSERS GPJ, HOOGDUIN CAL, SCHAAP CPDR. Prognostic factors in the behavioral treatment of panic disorders with and without agoraphobia. Behav Therapy 1994: 25: 689-708.
32. VAN DEN BRINK W. Meting van DSM-III persoonlijkheidspathologie. Betrouwbaarheid en validiteit van de SIPD-R en as II van de DSM-II. Academisch Proefschrift (Measuring DSM-III personality pathology. Reliability and validity of the SIDP-R and DSM-III Axis II. Thesis). Groningen: van Denderen, 1989.
33. HIRSCHFIELD RMA, KLERMAN GL, CLAYTON PJ, KELLER MB, MCDONALD-SCOTT P, LARKIN BH. Assessing personality: effects of the depressive state on measurement. Am J Psychiatry 1983: 140: 695-699.
34. REICH J, NOYES R, CORYELL W, O'GORMAN TW. The effect of state anxiety on personality measurement. Am J Psychiatry 1986: 143: 760-763.
35. RICCIARDI JN, BAER L, JENIKE MA, FISCHER SC, SHOLTZ D, BUTTOLPH ML. Changes in DSM-III-R axis diagnoses following treatment of obsessive-compulsive disorder. Am J Psychiatry 1982: 149: 829-831.